Nutrastar International Inc. (OTCQB:NUIN)

Leading Producer and Supplier of Premium Branded Consumer Products

Jan 2015 Safe Harbor Statement

This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Any statements about the Company's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These forward-looking statements are subject to a number of risks and uncertainties that cannot be predicted, quantified or controlled and that could cause actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements, including but not limited to fluctuations in customer demand, interruptions in the supply of raw materials, downturns in the Chinese economy, intensity of competition from other providers of the Company's products and services, general economic conditions, regulatory changes, and other information detailed in the "Risk Factors" section of the Company's Annual Report on Form 10−K for the year ended December 31, 2013 and the Company's subsequent SEC filings. Further, any forward-looking statement speaks only as of the date on which it is made, andthe Company undertakes no obligation to update any forward-looking statementor statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

2 Introduction

• Nutrastar International Inc. (“Nutrastar” or the “Company”) was established in 2006 in Harbin, the capital of Heilongjiang Province, with its production facilities in Zhaoyuan County in Northeast China • The Company is a leading producer and supplier of premium branded consumer products and one of the largest distributors of organic and specialty food products in Heilongjiang Province. Currently, the company has 330 employees, 149 in Sales • Top cultivator and producer of commercially cultivated Cordyceps Militaris (aka Cordyceps), a valuable ingredient product used in Traditional Chinese Medicine. Our patented proprietary cultivation process allows for commercial production on a mass scale • Launched beverage products featuring Cordyceps as a core ingredient in Q4 2010 and powder product in Q4 2013, currently in process of mass commercialization • Core product sold throughout China via direct sales and distribution network that covers more than 10 provinces • 2013 revenue of $43.3 million, gross profit of $33.7 million (77.8% gross margin), and net income of $22.2 million (51.1% net margin). 2014 revenue projection: $45 – 47 million with Cordyceps Militaris comparable gross and net margins.

3 Investment Highlights

Leading Producer with High Barriers to Entry • Patent protected cultivation process used to cultivate and commercialize Cordyceps Militaris • Due to the difficult and sensitive growing conditions required, current competitors are unable to scale and compete in a meaningful way

Supplier with Extraordinary Pricing Power • Gross margin grew from 65% in FY 2008 to 77.8% in FY 2013 • Customers generally pay cash in advance or COD; operating cash flow consistently exceeds net income

Outstanding Revenue Growth Opportunity • Commercialization of beverage and powder products allows company to reach consumers on a mass scale and further increase revenue • Any future capacity expansion can allow core 75% gross margin business to continue to grow revenue at 20 - 25% per year

Strong Management Team to Execute Growth Plan • Management has decades of experience in Chinese consumer products

4 Cordyceps Overview

• Cordyceps Militaris, also known as Cordyceps or “yong chong cao (蛹虫草)isa premium consumer product used in Traditional Chinese Medicine (TCM), derived from a fungus typically found in high altitude mountainous regions of China

• An extremely valuable ingredient used in nutraceutical and pharmaceutical products • Cordyceps has been consumed in TCM for nearly 1,500 years. It is believed to strengthen the immune system, improve the respiratory system, liver and kidney functions, and combat harmful effects from fatigue and aging

• Due to extremely sensitive natural growing conditions, traditionally it has been very difficult to cultivate on a commercial scale • After years of laboratory tests, Nutrastar developed the proprietary technology to commercially grow and produce the product in a controlled environment on a mass scale • Cordyceps sales made up 85.4% and 77.7% of total revenues for the 9 months of year 2014 and fiscal year 2013, respectively.

5 Growth Opportunity – Cordyceps

Favorable Supply / Demand Dynamics • Projected global demand will reach 1,550 tons a year by 2016 well exceeds aggregate production capacity of only 550 tons a year (Source: Market Survey of Cordyceps Militaris 2012, published by Qianinfo Consulting in 2012).

Production Capacity Expansion • Company completed the expansion of its production capacity from 72 tons to approximately 100 tons annual production capacity at end of 2013. Additional buildings available onsite for future production facilities expansion.

Economies of Scale / Barriers to Entry • Gross margin (78.2% for YTD 2014) for the core product will continue to increase if and when the company adds additional capacity to meet the demand • Company owns patent-protected proprietary technology used to cultivate and commercialize. Difficult for local producers to scale in a meaningful way

China Pharmaceutical-Related Consumer Products Market • China is the world’s fifth largest pharmaceutical market and expects to be the world’s largest market by 2020

6 Patented Cultivation Process

Major Ingredients Minor ingredient Wild strains 1 Mainly wheat & rice Culture fluid formulation Artificially selected wild strains

Shaking table Special steamer Culture fluid formulation and wild Strains planted into the culture medium after high 2 strains placed into the shaking temperature sterilizing. table & propagated

Spawn running Inoculation Propagated strains require spawn running with Propagated strains are placed 3 and without light. After about 30 to 35 days, the into the culture medium. mycelia are mature.

Cultivation 4 Period of growth in the presence Harvest of light at a specific temperature After growing about 30 days, harvest takes place. and humidity.

Packing Drying Dried finished product is packaged in small 5 The harvested fresh Cordyceps packages and sold to consumers directly. Large Militaris is dried packages are sold to pharmaceuticals companies as raw material.

7 Cultivated Cordyceps Militaris

Cultivation Process Harvesting and Sorting Process

8 Cordyceps Production Facilities

• Located in Zhaoyuan County, approximately 300 km from Harbin in Heilongjiang Province

• 75 total available buildings on site owned by the company

Production facilities • 20 buildings are currently in operation, producing approximately 100 tons in annual capacity.

• Additional 20 buildings in total are being used for production support

• Additional buildings onsite are available for future production capacity expansion

Structures which can be renovated for future expansion

9 Beverage & Powder Products

• Premium branded functional health drink and powder using Cordyceps as a core ingredient. Significant opportunity to expand our share in the consumer related product market by reaching consumers on a mass scale.

• Beverage initial rollout in Jiangsu commenced in Q4 2010, powder solution initial rollout in Q4 2013 in Northeastern China.

• Drinks are currently available in retail outlets in Jiangsu and Anhui Province. Powder are available in Harbin. Based on market demand, product offering realigned in Q1 2014.

• FY 2013 revenue was $7.5 million.

• Applied for fur manufacturing-related patents to the State Intellectual Property Office.

• Key target customers include: • Affluent • White-collar • Executives • Elderly • Outdoor sports enthusiasts

10 Beverage & Powder Product Line

4 versions of our functional health drink containing Cordyceps allow for a variety of distribution channels and marketing strategies depending on consumer demographic and point-of-sale (POS). Currently sold through distribution channels in Jiangsu and Anhui Provinces.

• 310 ml “Yang Yang Ba” Red Can - Retails for $0.50 – $0.75 USD - POS: supermarkets & convenience stores in April 2011

• 210 ml Gold / Silver (Light) Can - Retails for $2.00 – $2.50 USD - POS: supermarkets & convenience stores

• Instant Dissolves Package (Highest Concentration) - Retails for $30.00 USD - POS: Hotels, & high end establishments (spa and country club, etc)

11 Organic & Specialty Foods

• Through VIE entity, acts as sales agent / distributor to market and sell organic and specialty food products supplied by third-party producers.

• As a result of food supply issues & rising disposable income, there is a growing market demand for organic grown products in China. Organic, green producers are also available for government subsidies.

• Working with Northeast Agricultural University to ensure quality control and meet the highest food safety measures, the VIE entity began building greenhouses on existing production grounds.

• The Company plans strategic expansion of this segment of the business. Goal is to become one of the top producer of locally grown, organic & specialty food products.

• Expected first phase to complete in 2015.

12 Sales and Distribution

• Currently 149 dedicated sales personnel and 9 major key pharmaceutical customers / distributors covering more than 10 provinces in China for core Cordyceps product

• Large-pack products to HEILONGJIANG pharmaceutical companies JILIN • Small-pack products to XINJIANG LIAONING consumers or channel directly Beijing GANSU INNER MONGOLIA Tianjin HEBEI • Direct sales staff participate in NINGXIA SHANDONG trade shows and offer QINGHAI SHANXI

HENAN JIANGSU seminars / lectures to TIBET SHAANXI ANHUI Shanghai customers or channels in local HUBEI SICHUAN communities ZHEJIANG JIANGXI • Drinks are sold in Jiangsu and HUNAN GUIZHOU FUJIAN Anhui provinces. Powder are YUNNAN sold in Northeastern China GUANGXI GUANGDONG

HAININ

13 Research and Development

Strong R&D Capabilities • 21 full time employees • Collaboration with China Institute of Science

Unique Technology • Patent-protected proprietary technology used to cultivate and commercialize Cordyceps Militaris • Biotechnology and Processing Patents – 6 patents pending

New Products • Development of specialty beverage products such as functional health drink, alcoholic beverage and oral liquids - Drink: Initial rollout was in Q4 2010 - Powder: Initial rollout was in Q4 2013 - Tablets and capsules : Trial production to start in second half 2014

14 Management Team

Lianyun Han – Chairman and CEO • Over 10 years experience in green and organic food business • Shuaiyi Group Founder, Chief Executive Officer, President and Chairperson • Heilongjiang Daily Reporter, Director and Senior Economist • BA from Harbin Normal University

Robert Tick, CPA – Chief Financial Officer • Over 16 years experience in Finance / Accounting • Public accounting experience with PwC • Prior CFO and senior financial experience with high tech companies • M.B.A. and B.S. Accounting and Finance • Fluent in written and verbal Chinese

Hongbing Hua – Chief Marketing Officer • Instrumental in Wang Lao Ji Herbal Tea becoming a nationwide beverage brand • Beijing Huiyuan Beverage and Food Group Co., Ltd. Vice President & Planning Director, instrumental in Huiyuan becoming the No.1 juice brand in China

Lichen Wang – Head of R&D • Technical and Deputy Director of the Institute of Edible Fungus • University research in the field of edible fungus

15 Income Statement / Cash Flow Summary

YTD $M FY2009 FY2010 FY 2011 FY 2012 FY2013 2014

Revenue $15.3 $24.2 $34.2 $36.8 $43.3 $31.0

Gross Profit $10.8 $19.6 $26.0 $28.0 $33.7 $24.3

Gross Margin 70.2% 80.9% 75.9% 76.2% 77.8% 78.2%

Operating Income $8.9 $15.8 $21.5 $23.3 $29.6 $21.4

Operating Margin 58.1% 65.1% 62.8% 63.3% 68.2% 69.1%

Net Income $7.7 $13.4 $16.9 $17.2 $22.2 $16.1

Net Margin 50.3% 55.5% 49.6% 46.9% 51.1% 51.8%

Operating Cash Flow $9.3 $15.3 $18.8 $19.9 $24.3 $16.9

Note: Excludes one-time non-cash merger costs

16 Rapid Growth in Profitability

Growth in both revenue and margins drives net income consistently higher ($ = M USD)

CAGR: Revenue: 27.2% Net Income: 30.8%

17 Balance Sheet Summary

($=M USD) Dec. 31, 2013 Sep. 30, 2014

Cash and Cash Equivalents (*) $102.6 * $118.6 *

Accounts Receivable $0.1 $0.1

Inventory $0.7 $1.3

Total Current Assets $104.6 $120.8

Total Assets $121.2 $136.1

Accounts Payable and Accruals $4.1 $3.5

Total Current Liabilities $5.1 $4.6

Total Shareholders’ Equity $116.1 $131.5

* USD cash equivalents denominated in RMB, current RMB to US$ exchange rate approximately RMB 6.12 = US$1. Deposit accounts are with top tier financial institutions in China. Confirmed and verified by Crowe Horwath, top 10 independent accounting firm. Under PRC law, convertibility of the RMB is subject to restrictions and limitations by the State Administration of Foreign Exchange. Please see year 2013 Form 10-K for detail disclosures.

18 Growth Strategy

• Utilize internally generated funds to continue production capacity expansion across all business lines (Cordyceps, Beverages and Organic and Specialty Foods)

• Expand market and distribution network: • Continue beverage and powder commercialization and distribution expansion • Further the expansion of our organic and specialty food business to include organic produce and other products • Expand Cordyceps products to other parts of China • Select products for international markets (powder, tablets and capsules), current expected timing in 2015 pending market validation

• Build consumer brand awareness through targeted marketing strategies

• Continue technology and product innovation through existing R&D platform

• Consider potential strategic acquisitions to acquire complementary product lines and distribution channels

19 Investment Summary

• Leading market position with high barriers to entry

• Top producer with expanding production capacity

• Growth opportunity in Cordyceps driven by large gap in global supply and demand

• Well positioned premium products meeting consumer demands

• Strong direct sales force and expanding national distribution network

• Innovative R&D team with cooperation from China Institute of Science

• Patent-protected proprietary technology

• Experienced management team with a strong track record

20 Contact Information

Nutrastar International Inc. Independent Auditor: 4/F Yushan Plaza Crowe Horwath (HK) CPA Limited 51 Yushan Road Hong Kong / Beijing Office Nangang District, Harbin, PRC 150090 River Mau Tel: +1 (408) 368-0254 Tel: + (852) 2894-6888 Robert Tick, Chief Financial Officer www.crowehorwath.hk Email: [email protected] www.nutrastarintl.com

Investor Relations: Legal Counsel: American Capital Ventures Pillsbury Winthrop Shaw Pittman LLP Howard Gostfrand / Richard Hull Washington D.C. Office Tel: +1 (305) 918-7000 Kevin Sun Email: [email protected] Tel: +1 (202) 663-8000 www.amcapventures.com www.pillsburylaw.com

21